Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium

FEBS Open Bio. 2023 Apr;13(4):713-723. doi: 10.1002/2211-5463.13577. Epub 2023 Feb 27.

Abstract

Adrenomedullin (AM) is a peptide with pleiotropic physiological functions that attenuates intestinal mucosal inflammation. However, the mechanism underpinning mucosal protection by AM is not fully understood, and its effect on intestinal epithelial cells remains unclear. Here, we investigated the effects of AM on junctional molecules in primary-cultured murine intestinal epithelial cells and discovered that AM upregulates claudin-4 expression. In a mouse model of dextran sulfate sodium-induced colitis, AM administration also enhanced claudin-4 expression and accelerated mucosal regeneration. Furthermore, AM reversed TNFα-mediated downregulation of claudin-4 and loss of cell-cell adhesion of the HCT116 human intestinal epithelial cell line in vitro. These results indicate that AM may enhance intestinal epithelial integrity by upregulating claudin-4 expression.

Keywords: adrenomedullin; claudin-4; inflammatory bowel disease; mucosal regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenomedullin* / adverse effects
  • Adrenomedullin* / metabolism
  • Animals
  • Claudin-4
  • Colitis* / chemically induced
  • Epithelium / metabolism
  • Humans
  • Mice

Substances

  • Adrenomedullin
  • Claudin-4